Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00377910
Other study ID # ON-02-012-OSi
Secondary ID
Status Completed
Phase Phase 4
First received September 18, 2006
Last updated March 28, 2014
Start date March 2008
Est. completion date January 2009

Study information

Verified date March 2014
Source Northern Orthopaedic Division, Denmark
Contact n/a
Is FDA regulated No
Health authority Denmark: The Danish National Committee on Biomedical Research EthicsDenmark: Danish Dataprotection Agency
Study type Interventional

Clinical Trial Summary

Chronic achilles tendinopathy is a common disease especially in adults. The golden standard in treatment has up to now been excentric exercises but with varying success. A new hypothesis is that this chronic pain is due to neo vascularisation. In a pilot study sclerosing injections with polidocanol have had a successful efficacy. Our aim is to study the efficacy of polidocanol as a treatment in a randomised controlled setting on a larger scale.


Description:

48 patients with chronic achilles tendinopathy for more than 3 months who have tried excentric exercises without success will be randomised to either polidocanol or lidocaine injections if having ultrasound verified neo-vascularisation.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date January 2009
Est. primary completion date January 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 year old, Ultrasound verified Achilles tendinopathy with neo-vascularisation, pain duration more than three months, excentric exercises for at least three months, women: negative pregnancy test, safe anticonceptive

Exclusion Criteria:

- Dementia, mental disease or other illness incompatible with participation, no ultrasound verified neo-vascularisation, any illness which contraindicate the use of Polidocanol or Lidocaine, granulation tissue of more than 50 % of the Achilles tendon, ability of lying in prone position, women: pregnancy or breastfeeding,

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Aethoxysclerol
2 ml Aethoxysclerol 10 mg/ml 2 ml. lidocaine 10mg/ml

Locations

Country Name City State
Denmark Aalborg University Hospital Aalborg

Sponsors (2)

Lead Sponsor Collaborator
Northern Orthopaedic Division, Denmark Aarhus University Hospital

Country where clinical trial is conducted

Denmark, 

References & Publications (1)

Alfredson H, Ohberg L. Sclerosing injections to areas of neo-vascularisation reduce pain in chronic Achilles tendinopathy: a double-blind randomised controlled trial. Knee Surg Sports Traumatol Arthrosc. 2005 May;13(4):338-44. Epub 2005 Feb 2. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain during physical activity which usually causes pain 3 and 6 months No
Secondary Achilles tendon pressure measuring until pain release. 3 and 6 months No
Secondary Pain while resting. 3 and 6 months No
Secondary Patient evaluation of treatment efficacy 3 and 6 months No
Secondary FAOS 3 and 6 months No
Secondary AOFAS 3 and 6 months No
Secondary Number of neo-vascularisation. day 0, 1 and 3 months Yes
Secondary Localisation of the neo-vascularisation day 0, 1 and 3 months No